- Home
- PMAX vs XAIR Comparison
PMAX vs XAIR Comparison
Compare PMAX & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PMAX | XAIR |
|---|---|---|
| Founded | 2019 | 2011 |
| Country | Hong Kong | United States |
| Employees | 53 | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7M | 4.3M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | PMAX | XAIR |
|---|---|---|
| Price | $1.55 | $5.46 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 189.8K | 85.2K |
| Earning Date | 05-12-2026 | 06-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,679,000.00 |
| Revenue This Year | N/A | $122.00 |
| Revenue Next Year | N/A | $58.15 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 107.26 |
| 52 Week Low | $0.20 | $0.33 |
| 52 Week High | $5.20 | $8.19 |
Technical Indicators
Market Signals| Indicator | PMAX | XAIR |
|---|---|---|
| Relative Strength Index (RSI) | 38.10 | 69.80 |
| Support Level | $0.24 | $0.64 |
| Resistance Level | $2.69 | $8.19 |
| Average True Range (ATR) | 0.15 | 0.46 |
| MACD | -0.00 | 0.06 |
| Stochastic Oscillator | 7.94 | 65.88 |
Price Performance
Historical ComparisonAbout PMAX Powell Max Limited
Powell Max Ltd operates as a financial communications platform supporting listed companies and IPO applicants throughout the capital markets lifecycle. Substantially all of the company's revenue is generated from Hong Kong. The group focused on supporting the disclosure, reporting, and transaction needs of corporate clients and their advisors. Its mission is to combine industry knowledge, execution capabilities, and a commitment to service to deliver accurate, timely, and reliable solutions for customers.
About XAIR Beyond Air Inc.
Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos. The company generates majority of revenue from Beyond Air. It has developed the Beyond Air NO generator and delivery system which it call LungFit, a novel and precise delivery system that uses NO generated from ambient air with a novel NO generator, the ionizer. Its product and technology includes LungFitPH.